The collaboration aims to integrate Nanowear’s at-home AI-based nanotechnology biomarker diagnostic platform with Satio’s at-home blood draw diagnostics and drug delivery systems/patches. This would combine time-synchronous, in vivo and in vitro diagnostics for precision therapeutics and individualized AI-based risk assessment.
Nanowear’s SimpleSense AI technology delivers a full cardiometabolic assessment and a continuous picture of individualized health. It simultaneously and time-synchronously collects more than 85 clinically validated cardiopulmonary and hemodynamic biomarkers. The company recently partnered with Dexcom to ingest glucose data from continuous glucose monitors (CGMs).
Satio develops patch-based adhesive technology to shift care from clinics to home for blood-based diagnostics and drug delivery. The company recently completed a Small Business Innovation Research (SBIR) contract for its intradermal drug delivery system.
Nanowear and Satio plan to use their collaboration to explore multiple pathways. One initiative aims to integrate Satio’s SatioDot dry blood spot and SatioDraw whole blood draw in vitro patches with SimpleSense. This would merge blood and genotype biomarkers with cardiometabolic physiological data within a single digital app.
A complementary approach could see SimpleSense biomarkers incorporated into the SatioRx telehealth drug delivery system. Additionally, the companies plan to jointly promote their technologies to further accelerate innovation in digital healthcare.
Namal Nawana, Satio chair and founder, says the partnership can help ensure ease of mind for patients and decision-making for clinicians.
“This collaboration of the technologies that combine these key determinants of human health, result in a first-of-its-kind platform that will truly unlock early diagnosis and precision medicine,” said Venk Varadan, CEO and co-founder of Nanowear. “When all of the health determinant biomarkers are available through a single data fire hose, AI precision medicine will make us healthier and save our healthcare system trillions.”
